Cargando…
Acute Myeloid Leukaemia in Its Niche: the Bone Marrow Microenvironment in Acute Myeloid Leukaemia
PURPOSE OF REVIEW: Acute myeloid leukaemia (AML) is a heterogeneous malignancy for which treatment options remain suboptimal. It is clear that a greater understanding of the biology of the AML niche will enable new therapeutic strategies to be developed in order to improve treatment outcomes for pat...
Autores principales: | Ladikou, E. E., Sivaloganathan, H., Pepper, A., Chevassut, T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7012995/ https://www.ncbi.nlm.nih.gov/pubmed/32048054 http://dx.doi.org/10.1007/s11912-020-0885-0 |
Ejemplares similares
-
Chronic Lymphocytic Leukaemia in 2020: the Future Has Arrived
por: Milne, Kate, et al.
Publicado: (2020) -
Molecular Landscape of Acute Myeloid Leukemia: Prognostic and Therapeutic Implications
por: Marando, Ludovica, et al.
Publicado: (2020) -
Post-Induction Treatment for Acute Myeloid Leukemia: Something Change?
por: Jaramillo, Sonia, et al.
Publicado: (2021) -
Access to Therapy for Acute Myeloid Leukemia in the Developing World: Barriers and Solutions
por: Meillon-Garcia, Luis Antonio, et al.
Publicado: (2020) -
What Do We Currently Know About Chronic Myeloid Leukemia (CML) and COVID-19?
por: Delgado, Nancy, et al.
Publicado: (2022)